ifosfamide has been researched along with Adrenal Cancer in 9 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " In this case report, we treated a 20-year-old male patient with cyclophosphamide, doxorubicin, vincristine, dexamethasone, and methotrexate and cytarabine chemotherapy following a diagnosis of Stage IV Burkitt lymphoma." | 4.89 | Unusual presentation of Ewing sarcoma in the adrenal gland: a secondary malignancy from a survivor of Burkitt lymphoma. ( Choi, KH; Hyun, JY; Kim, JH; Kim, SJ; Kim, WS; Ko, YH; Lee, J; Lee, JY; Lim, SH, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (33.33) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lim, SH | 1 |
| Lee, JY | 2 |
| Kim, JH | 1 |
| Choi, KH | 1 |
| Hyun, JY | 1 |
| Ko, YH | 1 |
| Lee, J | 1 |
| Kim, SJ | 1 |
| Kim, WS | 1 |
| Gutweiler, JR | 1 |
| Yu, DC | 1 |
| Kim, HB | 1 |
| Kozakewich, HP | 1 |
| Marcus, KJ | 1 |
| Shamberger, RC | 1 |
| Weldon, CB | 1 |
| Yoo, SH | 1 |
| Kim, KR | 1 |
| Hong, SJ | 1 |
| Cho, KJ | 1 |
| Sidoni, A | 1 |
| Magro, G | 1 |
| Cavaliere, A | 1 |
| Scheibel, M | 1 |
| Bellezza, G | 1 |
| Bagatell, R | 1 |
| Rumcheva, P | 1 |
| London, WB | 1 |
| Cohn, SL | 1 |
| Look, AT | 1 |
| Brodeur, GM | 1 |
| Frantz, C | 1 |
| Joshi, V | 1 |
| Thorner, P | 1 |
| Rao, PV | 1 |
| Castleberry, R | 1 |
| Bowman, LC | 1 |
| Kattan, J | 1 |
| Culine, S | 1 |
| Theodore, C | 1 |
| Droz, JP | 1 |
| Matsumoto, K | 2 |
| Miyajima, Y | 2 |
| Numata, S | 1 |
| Mori, H | 1 |
| Fukuda, M | 2 |
| Horibe, K | 2 |
| Kondo, M | 1 |
| Inaba, J | 1 |
| Miyashita, Y | 1 |
| Trillet, V | 1 |
| Chauvin, F | 1 |
| Champel, F | 1 |
| Bernard, JP | 1 |
| Brune, J | 1 |
| Clavel, M | 1 |
| Cordier, JF | 1 |
| Emonot, A | 1 |
| Guérin, JC | 1 |
| Kalb, JC | 1 |
4 reviews available for ifosfamide and Adrenal Cancer
| Article | Year |
|---|---|
Unusual presentation of Ewing sarcoma in the adrenal gland: a secondary malignancy from a survivor of Burkitt lymphoma.
Topics: Adrenal Gland Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophos | 2013 |
Primary retroperitoneal dysgerminoma presenting as an adrenal tumor: a case report and literature review.
Topics: Adolescent; Adrenal Gland Neoplasms; Adrenalectomy; Antineoplastic Combined Chemotherapy Protocols; | 2011 |
[Primary adrenal angiosarcoma].
Topics: Adrenal Gland Neoplasms; Adrenalectomy; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chem | 2003 |
[Small cell lung carcinoma. Value of the evaluation of extension for the therapeutic strategy].
Topics: Adrenal Gland Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Clin | 1990 |
3 trials available for ifosfamide and Adrenal Cancer
| Article | Year |
|---|---|
Outcomes of children with intermediate-risk neuroblastoma after treatment stratified by MYCN status and tumor cell ploidy.
Topics: Abdominal Neoplasms; Adolescent; Adrenal Gland Neoplasms; Antineoplastic Combined Chemotherapy Proto | 2005 |
Phase II trial of ifosfamide, fluorouracil, and folinic acid (FIFO regimen) in relapsed and refractory urothelial cancer.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms | 1995 |
[Small cell lung carcinoma. Value of the evaluation of extension for the therapeutic strategy].
Topics: Adrenal Gland Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Clin | 1990 |
3 other studies available for ifosfamide and Adrenal Cancer
| Article | Year |
|---|---|
Hepatoblastoma presenting with focal nodular hyperplasia after treatment of neuroblastoma.
Topics: Adrenal Gland Neoplasms; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplas | 2008 |
[Combination chemotherapy of ifosfamide and etoposide for advanced neuroblastoma].
Topics: Adrenal Gland Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Dr | 1995 |
Outcome prediction by molecular detection of minimal residual disease in bone marrow for advanced neuroblastoma.
Topics: Adrenal Gland Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Mar | 2001 |